US Patent 9474727 Pharmaceutical compositions of curcumin

Patent 9474727 was granted and assigned to Cadila Pharmaceuticals on October, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Cadila Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9474727

Patent Inventor Names

Vandana Bharat Patravale0

Indravadan Ambalal Modi0

Rajneesh Ramesh Shrivastava0

Ritu Nitin Laddha0

Ashish Premkumar Gogia0

Bakulesh Mafatlal Khamar0

Chirag Chandrakant Goda0

Dinesh Balkunje Shenoy0

...

Date of Patent

October 25, 2016

Patent Application Number

13822539

Date Filed

September 12, 2011

Patent Primary Examiner

‌

Sreeni Padmanabhan

Patent abstract

The present invention relates to stable liquid pharmaceutical compositions of curcumin or its pharmaceutically acceptable salts or its derivatives with higher curcumin concentration and improved bioavailability without the use of buffer and/or molecular aggregation inhibitor(s). In accordance with present invention the curcumin is in the solubilized form to make a stable liquid pharmaceutical composition.